Clinical trial
Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam…
NCT00307723 · Massachusetts General Hospital, Other · Terminated
Key facts
| NCT number | NCT00307723 |
|---|---|
| Title | Study of Bevacizumab in Combination With 5-FU, Oxaliplatin and External Beam Radiation Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer |
| Official title | A Tolerability and Efficacy Study of the Angiogenesis Inhibitor Bevacizumab in Combination With 5-Fluorouracil, Oxaliplatin, and External Beam Radiation Therapy Followed by Gemcitabine and Bevacizumab for Locally Advanced Pancreatic Cancer |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Dana-Farber Cancer Institute Beth Israel Deaconess Medical Center Genentech, Inc. Industry Sanofi |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma |
| Intervention type | Drug, Procedure |
| Interventions | bevacizumab, 5-Fluorouracil, Oxaliplatin, gemcitabine, External Beam Radiation Therapy |
| Enrollment | 52 |
| Start date | May 1, 2006 |
| Primary completion | Aug 1, 2007 |
| Completion | Jul 1, 2009 |
| First posted | Mar 28, 2006 |
| Last update posted | Aug 10, 2009 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: